Why the study?
Cardiomyopathy during pregnancy or postpartum is a leading cause of maternal mortality, and symptom overlap causes diagnostic delays, creating a need for screening tools.
Does the adapted KCCQ-P questionnaire detect left ventricular systolic dysfunction in pregnant and postpartum women?
Does the adapted KCCQ-P questionnaire detect left ventricular systolic dysfunction in pregnant and postpartum women?
Answers are grounded in this paper and cite their sources.
The adapted KCCQ-P questionnaire effectively detects apparent and subclinical left ventricular systolic dysfunction in pregnant and postpartum women, offering a potential screening tool for pregnancy-related cardiomyopathy.
Cardiomyopathy occurring during pregnancy or postpartum represents a leading cause of maternal mortality. An overlap between pregnancy-associated symptoms and symptoms of cardiomyopathy contributes to delays in diagnosis. To address the need for screening and improve the diagnosis of pregnancy-related cardiomyopathy, we sought to evaluate the association between cardiovascular symptoms, an adapted version of the 12-item Kansas City Cardiomyopathy Questionnaire for pregnancy (KCCQ-P) and left ventricular systolic dysfunction (LVSD). We conducted a single-arm prospective observational study of pregnant and postpartum participants enrolled between October 2021 and October 2022. A symptom questionnaire, KCCQ-P, and a resting echocardiogram were performed. The primary study outcome was LVSD, defined as left ventricular ejection fraction (LVEF) < 50%. We sub-divided those with LVEF (≥50%) into subclinical LVSD (left ventricular global longitudinal strain (GLS) > –18), and no LVSD (GLS ≤ −18). Ninety women were included in the final analysis. The median age was 31 years (Q1: 28, Q3: 35), 37% identified as Non-Hispanic White, 30% as Non-Hispanic Black, and 23% as Hispanic or Latino. KCCQ-P total scores were markedly lower with LVSD (median: 30.2; Q1: 22.9, Q3: 61.5) vs. subclinical LVSD (median: 60.7; Q1: 47.0, Q3: 76.2) vs. no LVSD (median: 86.5; Q1: 62.5, Q3: 95.8) p < 0.001. KCCQ-P score was able to detect LVSD with an AUC of 0.848. While individual cardiovascular symptoms were not associated with LVSD, KCCQ-P scores were significantly lower in those with apparent and subclinical LVSD and may be useful as a screening tool pending additional evaluation in larger cohorts.
No takes yet. Share an insight, caveat, or question.
Adedinsewo et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: